CDTI invests, together with Asabys and AdBio Partners, in Orikine Bio

by CDTI Innovación

Orikine Bio develops therapies capable of 'reprogramming' the immune system, similar to how software engineers rewrite faulty code to repair computer systems.

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Xcalibur Smart Mapping strengthens its g...

by MCH Private Equity

​Xcalibur Smart Mapping, recognised as the global leader in airborne...

Photos Stream